Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Chronic Recalcitrant or Unresponsive Central Serous Chorioretinopathy Via Electromagnetic Stimulation And Platelet- Rich Plasma

NCT04224831 is registered in ClinicalTrials.gov with Ankara Universitesi Teknokent as lead sponsor.

NCT NCT04224831
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04224831 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Chronic Recalcitrant or Unresponsive Central Serous Chorioretinopathy Via Electromagnetic Stimulation And Platelet- Rich Plasma
Lead sponsor
Ankara Universitesi Teknokent
Phase
Not applicable
Overall status
Completed
Start date
December 1, 2018
Completion date
January 1, 2020
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

central serous chorioretinopathy, chronic central serous chorioretinopathy